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Background. Early recognition of viable myocardium after acute myocardial infarction
(AMI) is of clinical relevance, since affected segments have the potential of functional recovery.
Delayed contrast-enhanced magnetic resonance imaging (DCE-CMR) has been validated exten-
sively for the detection of viable myocardium. An alternative parameter for detecting viability is
the perfusable tissue index (PTI), derived using [15O]H2O positron emission tomography (PET),
which is inversely related to the extent of myocardial scar (non-perfusable tissue). The aim of the
present studywas to investigate thepredictive value ofPTIon recovery ofLV function as compared
to DCE-CMR in patients with AMI, after successful percutaneous coronary intervention (PCI).
Methods. Thirty-eight patients with ST elevationmyocardial infarction (STEMI) successfully
treated byPCIwere prospectively recruited. Subjectswere examined 1 week and 3 months (mean
follow-up time: 97 ± 10 days) after AMI using [15O]H2O PET and DCE-CMR to assess PTI,
regional function and scar. Viability was defined as recovery of systolic wall thickening ‡3.0 mm
at follow-up by use of CMR. A total of 588 segments were available for serial analysis.
Results. Atbaseline, 180 segmentsweredysfunctional and exhibitedDCE. Seventy-three (41%)
of these dysfunctional segments showed full recovery during follow-up (viable), whereas 107 (59%)
segments remained dysfunctional (nonviable). Baseline PTI of viable segments was 0.94 ± 0.09 and
was significantly higher compared to nonviable segments (0.80 ± 0.13, P < .001). The optimal cut-
off value for PTI was ‡0.85 with a sensitivity of 85% and specificity of 72%, and an area under the
curve (AUC) of 0.82. In comparison, a cut-off value of <32% for the extent of DCE resulted in a
sensitivity of 72% and a specificity of 69%, and an AUC of 0.75 (AUC PTI vs DCE P 5 .14).
Conclusion. Assessment ofmyocardial viability shortly after reperfusedAMI is feasible using
PET. PET-derived PTI yields a good predictive value for the recovery of LV function in PCI-
treated STEMI patients, in excellent agreement with DCE-CMR. (J Nucl Cardiol 2016)
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Abbreviations
AMI Acute myocardial infarction
CMR Cardiovascular magnetic resonance
LAD Left anterior descending artery
LCX Left circumflex artery
LGE Late gadolinium enhancement
LVEF Left ventricular ejection fraction
PCI Percutaneous coronary intervention
PTI Perfusable tissue index
RCA Right coronary artery
STEMI ST-segment elevation myocardial
infarction
INTRODUCTION
After an acute myocardial infarction (AMI), the
injured myocardium contains both reversibly damaged
(‘viable, or stunned’) and irreversibly damaged (‘non-
viable’) tissue, even after successful restoration of coro-
nary reperfusion. Early recognition of dysfunctional but
viable myocardium is of clinical relevance, since affected
segments have the potential of (complete) functional
recovery. Of the various diagnostic techniques available
for detecting viability in AMI, delayed contrast-enhanced
cardiac magnetic resonance imaging (DCE-CMR) has
been evaluated extensively, and it has been shown that the
extent of regional hyperenhancement is inversely related
to functional improvement after reperfusion.1,2 More
recently, the presence of microvascular injury has been
shown to have incremental value over DCE alone in
predicting viability.3 Nonetheless, the significance of
contrast patterns in AMI remains ambiguous, as other
reports have shown differences in contrast wash-out due
to ischemia-induced alterations in the pharmacokinetics
of gadolinium.4,5 Consequently, dysfunctional but viable
myocardium may also show hyperenhancement, thereby
limiting the accuracy of DCE-CMR for delineating viable
from necrotic myocardium in the (sub)acute phase of
myocardial infarction.
An alternative method to detect myocardial viability
is the perfusable tissue index (PTI), which is a positron
emission tomography (PET)-derived parameter. PTI
reflects the fraction of myocardium that is able to
rapidly exchange water, i.e., that is perfusable by water.6
Consequently, differentiation between viable and non-
viable myocardium is based on the concept that areas of
necrotic tissue cannot exchange water rapidly. Recently,
it was shown that parametric PTI images can be
generated from a single PET-CT scan.7 Indeed, prelim-
inary data indicate that PTI may be used as a predictor of
functional recovery in AMI.8 The aim of the present
study was to investigate the predictive value of PTI on
recovery of LV function after successful primary PCI for
AMI compared against a background of DCE-CMR.
MATERIALS AND METHODS
Study Population
Thirty-eight consecutive patients with an acute ST eleva-
tion myocardial infarction (STEMI), presenting at the
catheterization laboratory within 6 h after onset of symptoms
and successfully treated by primary PCI (i.e., thrombolysis in
myocardial infarction (TIMI) III flow after coronary stenting),
were prospectively included in this study. STEMI was defined
according to the European Society of Cardiology/ACCF/AHA/
World Heart Federation Task Force for the Universal Defini-
tion of Myocardial Infarction as new ST elevation at the J point
in at least 2 contiguous leads of C2 mm (0.2 mV) in men or
C1.5 mm (0.15 mV) in women in leads V2-V3 and/or of
C1 mm (0.1 mV) in other contiguous chest leads or the limb
leads, in the absence of left ventricular (LV) hypertrophy or
left bundle-branch block (LBBB).9 As described previously,10
all patients were treated according to the ESC guidelines for
management of STEMI.11 Patients with three-vessel disease
and those who were hemodynamically unstable were excluded,
since repeat revascularization therapies were deemed probable
during study follow-up. Other exclusion criteria were previous
myocardial infarction or coronary revascularization proce-
dures. Patients were examined 4-6 days and 3 months after the
cardiac event with [15O]H2O PET and CMR. No adverse
events occurred between primary PCI and the follow-up
imaging sessions, and medication was kept constant between
scans. The study was approved by the institutional review
board, and all subjects signed an informed consent form within
24 h after PCI. The clinical trial was registered (http://www.
trialregister.nl) under number NTR3164.
PET Image Acquisition
[15O]H2O PET scans were acquired between 4 and 6 days
and at 90 days after PCI using a Gemini TF-64 (Philips
Healthcare, Best, The Netherlands) PET/CT scanner.
[15O]H2O (370 MBq) was injected as a 5 mL bolus
(0.8 mLs-1) followed by a 35-mL saline chaser at a rate of
2 mLs-1 with the simultaneous start of a 6-min dynamic scan
sequence min. This scan was followed immediately by a low-
dose (LD) CT scan during normal breathing to correct for
attenuation (55 mAs; rotation time 1.5 s; pitch 0.825; colli-
mation 640.625). The rate pressure product (RPP), being the
product of heart rate and systolic blood pressure, was mon-
itored during all PET studies.
PET Image Analysis
All scans were checked for misalignment between LD CT
and [15O]H2O scans, but none of the studies required
See related editorial, doi:10.1007/s12350-
016-0425-3.
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corrections. All images were reconstructed using the three-
dimensional row action maximum likelihood algorithm into 22
frames (1 9 10, 8 9 5, 4 9 10, 2 9 15, 3 9 20, 2 9 30, and
2 9 60 s) applying all appropriate corrections, i.e., normal-
ization, dead time, decay, scatter, randoms, and attenuation
based on the corresponding LD CT scan. Parametric PTI
images were generated as previously described using the in-
house developed software package Cardiac VUer.7 In brief,
parametric images of perfusable tissue fraction (PTF), and
arterial and venous blood volume fractions were calculated
using a basis function implementation of the standard single
tissue compartment model for [15O]H2O.
12,13 Parametric
images of arterial and venous blood volume fractions were
subtracted from normalized CT transmission images, resulting
in parametric anatomical tissue fraction (ATF) images. Para-
metric PTI images were calculated as the ratio of PTF and
ATF. Finally, 16 myocardial volumes of interest (VOIs) were
defined manually on parametric PTF images, according to the
16 segments model of the American Heart Association,14 after
which this VOI template was projected onto the parametric
PTI images. Furthermore, parametric myocardial blood flow
(MBF) images were generated and quantitatively analyzed
using Cardiac VUer. MBF was expressed in mL/min/g of
perfusable tissue.
CMR Image Acquisition
CMR was performed between 4 and 6 days and at 90 days
after PCI using a 1.5 Tesla MR-scanner (Avanto, Siemens,
Erlangen, Germany) with the use of a dedicated phased array
cardiac receiver coil. Functional imaging was performed using
retrospectively ECG-gated steady-state free precession cine
imaging with breath holding. Standard 3 long axis orientations
(4, 3, and 2 chamber views) and short axis orientationwith full LV
coverage were obtained (typical parameters: voxel size
*1.6 9 1.9 9 5.0 mm, slice thickness 5.0 mm, slice gap
5.0 mm, TR/TE 3.2/1.6 ms, flip angle 758, field of view
360 9 400 mm, temporal resolution\50 ms). After administra-
tion of 0.2 mmol/kg gadolinium, DCE images were acquired
after 10-15 min, using a 2-dimensional segmented inversion-
recovery gradient-echo pulse sequence, with individual correc-
tion of the inversion time to null the signal of normalmyocardium
(slice thickness 5.0 mm, slice gap 5.0 mm, field of view
360 9 400 mm, pixel size*1.4 9 1.4 mm, TR 2x RR interval,
typical inversion time 250-350 ms). Cine and DCE images of
each patient were matched by slice position.
CMR Image Analysis
Analysis was performed with dedicated off-line software
(QMassMR v7.5, Medis, Leiden, the Netherlands)15 Cine images
were analyzed by tracing endocardial and epicardial myocardial
borders in both end-diastolic and end-systolic phases. From these
slices, myocardial volumes and ejection fraction were calculated.
Left ventricular end-diastolic and end-systolic volumes were
indexed for body surface area (LVEDVi and LVESVi, respec-
tively)16 Systolic wall thickening (SWT) was calculated by
subtracting end-diastolic from end-systolic wall thickness.
Myocardial segments were considered to be dysfunctional if
SWT was\3 mm, based on the mean SWT of 4.4 ± 0.7 mm
(mean ± 2 SD) in a group of 10 healthy volunteers (age 50-
75 years)3 Accordingly, viability was defined as complete
recovery of systolic wall thickening (SWT) C3.0 mm at fol-
low-up3,17 Quantification of infarct size and the size of the area
containing microvascular injury (MVI) was performed on the
short axis DCE images. CMR images were analyzed according to
the 16-segment AHA model as used for the parametric PET
images. The amount of DCE was calculated using the full-width
at half-maximum method18 All areas of enhancement were
quantified by computer-assisted planimetry on each of the short-
axis images and the segmental extent of enhancement was
expressed as a percentage of the segmental area.MVIwas defined
as a hypoenhanced area within the hyperenhanced infarcted
myocardium19 MVI was included in the calculation of total
infarct size. The extent of MVI was calculated for each patient,
and expressed as the sum of the segments with MVI, as a
percentage of the number of segments scored.
Statistical Analysis
Continuous variables are presented as mean ± SD, and
categorical data are summarized as frequencies and percent-
ages. The significance of intra-individual differences between
baseline and follow-up was assessed using the paired Student’s
t test. Inter-individual differences between viable and non-
viable myocardium were assessed using the unpaired Student’s
t-test. Multiple datasets were compared using analysis of
variance (ANOVA), and specific differences were identified
using Student’s t-test with Bonferroni inequality adjustment.
To identify independent predictors of LVEF at baseline and the
change in LVEF between baseline and follow-up, multivari-
able linear regression analyses with a stepwise manual
backward selection were applied and a removing probability
for each variable of C0.1, and presented with standardized b-
coefficients. Receiver operating characteristic (ROC) curves
were generated for PTI, MBF, and DCE for the prediction of
myocardial viability assessed by CMR. The area under the
curve (AUC) was considered a measure of accuracy to
discriminate between viable and non-viable myocardium. All
statistical tests were 2 tailed, and a P value of B.05 was
considered statistically significant. All statistical analyses were
performed using the IBM SPSS software package (IBM SPSS
Statistics 22, Chicago, IL, USA).
RESULTS
Baseline patient characteristics are listed in Table 1.
None of the patients suffered from re-infarction, repeat
revascularization, or hospitalization for heart failure
between baseline and follow-up study.
Global Analysis
There was no significant difference between LVEF
at baseline and follow-up (i.e., 50.1 ± 7.3% vs
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51.0 ± 8.4%, P = .34). LVEDVi and LVESVi averaged
92 ± 12 and 47 ± 12 mL/m2 at baseline, which were not
significantly different at follow-up (i.e., 95 ± 19 mL/m2,
P = .29, and 48 ± 18 mL/m2, P = .86, respectively).
DCE averaged 20 ± 12% of total LV mass at baseline,
which was significantly reduced at follow-up (12 ± 7%,
P\ .001). MVI was present in 22/38 (58%) of patients
at baseline, and in none at follow-up. When present,
MVI affected an average of 5 ± 2 segments (out of 16,
i.e., 31 ± 14%) per patient.
PTI at baseline was 0.87 ± 0.06 and was not signif-
icantly different at follow-up (0.88 ± 0.05, P = .59).
PTF andATF did also not change from baseline to follow-
up, i.e., from 0.66 ± 0.06 to 0.65 ± 0.05 (P = .27) and
from 0.76 ± 0.05 to 0.75 ± 0.03 (P = .09), respectively.
There was a significant reduction in restingMBF between
baseline and follow-up, changing from 0.97 ± 0.22 to
0.87 ± 0.15 mL/min/g (P = .01). The heart rate dropped
from 66 ± 11 to 62 ± 10 b/pm (P = .02) between base-
line and follow-up. Systolic blood pressure increased
from 106 ± 15 to 111 ± 11 mmHg (P = .01), whereas
diastolic blood pressure remained unchanged
(59 ± 8 mmHg vs 62 ± 8, P = .20). Overall, the RPP
was not significantly different between PET-studies
(7019 ± 1741 vs 6946 ± 1484 mmHg/min, P = .85),
indicating comparable hemodynamic conditions.
Regional Analysis
A total of 588 (97%) out of 608 segments were
available for serial analysis. Twenty segments were
excluded based on insufficient quality. A total of 331
remote segments were normokinetic at baseline and
showed no contrast enhancement. These segments were
defined as remote myocardium. A total of 257 segments
showed SWT of less than 3 mm, of which 180 (70%)
exhibited DCE and were located in the myocardial
territory of the culprit-artery. All patients had dysfunc-
tional segments with DCE, with an average of 5 ± 3
segments per patient. These latter segments were defined
as infarcted myocardium.
Infarcted vs remote myocardium. PTI was
significantly reduced in infarcted vs remote myocardium
(0.86 ± 0.14 vs 0.94 ± 0.10, P = .001). Resting MBF
averaged 0.93 ± 0.21 mL/min/g in the infarcted myo-
cardium vs 0.96 ± 0.23 mL/min/g in remote
myocardium (P = .58). SWT was severely depressed
in infarcted myocardium compared with remote myo-
cardium (1.4 ± 1.1 vs 4.1 ± 1.0 mm, P\ .001).
Additional baseline PET and CMR data, subdivided
per quartile of infarct transmurality, are summarized in
Table 2.
At follow-up, PTI, PTF, and ATF of infarcted
myocardium remained unchanged (0.88 ± 0.14,
0.64 ± 0.09, 0.74 ± 0.09, all P = NS vs baseline).
Resting MBF in infarcted myocardium, however, was
significantly reduced compared with remote myocar-
dium (0.80 ± 0.19 vs 0.88 ± 0.15 mL/min/g, P = .05).
SWT of infarcted myocardium significantly improved to
2.3 ± 1.7 mm (P\ .001 vs baseline). Follow-up PTI,
PTF, ATF, DCE, and SWT data for remote myocardium
were all comparable to baseline values (data not shown).
Viable vs non-viable. Of the 180 infarct-related
myocardial segments, 73 showed recovery during fol-
low-up and were classified as viable (i.e., stunned
myocardium), whereas 107 segments remained dysfunc-
tional and were classified as non-viable. Baseline PTI of
viable segments was 0.94 ± 0.09, which was signifi-
cantly higher than that of non-viable segments
(0.80 ± 0.13, P\ .001). The extent of DCE at baseline
averaged 26 ± 24% in viable segments vs 59 ± 27% in
non-viable segments (P\ .001).
SWT of viable segments improved from 1.8 ± 1.0
to 4.0 ± 1.0 mm (P\ .001), whereas SWT of non-
viable segments did not change (1.2 ± 1.1 mm vs
1.1 ± 1.0, P = .70). Correspondingly, MBF in viable
segments was preserved at follow-up (0.91 ± 0.23 mL/
min/g), whereas MBF in non-viable segments was
reduced to 0.70 ± 0.25 mL/min/g (P\ .001 vs base-
line). There was a significant difference between the
presence of MVI at baseline in viable and non-viable
Table 1. Baseline characteristics
Characteristic AMI (n 5 38)
Male sex 33 (87%)
Age (years) 58 ± 9





Smoking history 29 (76%)
Family history 16 (42%)
Duration of symptoms (h) 1.7 ± 1.2
Time to reperfusion (h) 2.0 ± 1.2





TIMI-3 flow grade after PCI 35 (92%)
AMI, acute myocardial infarction; BMI, body mass index;
CAD, coronary artery disease; CK-MB, creatine kinase-MB;
LAD, left anterior descending; RCx, ramus circumflex; RCA,
right coronary artery; TIMI, thrombolysis in myocardial
infarction
Timmer et al Journal of Nuclear Cardiology
In vivo assessment of myocardial viability after acute myocardial infarction
segments (29% vs 45%, P\ .001). Figure 1 illustrates
the evolution of PTI, MBF, and DCE for viable and non-
viable myocardium over time, in relation to remote
myocardium.
Prediction of Function and Recovery
Regional recovery. Figure 2 depicts the values
of PTI,DCE, andMBF for predictingmyocardial viability
(PTI: AUC 0.82, CI 0.76-0.88; DCE: AUC 0.75, CI 0.67-
0.82; resting MBF: AUC 0.53, CI 0.44-0.62). The AUC
was not significantly different between PTI and DCE
(P = .14). The optimal cut-off value for the PTI was
C0.85, yielding a sensitivity, specificity, positive predic-
tive value (PPV) and negative predictive value (NPV) of
85%, 72%, 67%, and 88%, respectively. In comparison, a
cut-off value of\32% for the extent of segmental DCE
resulted in a sensitivity of 72% and a specificity of 69%,
with a PPV of 58% and aNPV of 80%. Figure 3 illustrates
the baseline and follow-up data for regional function in the
myocardial territory of the culprit artery, subdivided for
segments with a PTI C0.85 and\0.85.
Global function and recovery. Table 3
demonstrates univariable and multivariable linear
regression analyses for the prediction of baseline LVEF
and the change in LVEF between baseline and follow-
up. PTI C0.85, infarct size, presence and extent of MVI
were all predictors of baseline LVEF. Multivariable
analysis revealed that the extent of MVI was the
strongest and single independent predictor of baseline
LVEF (b = -0.69; P\ .001). For the change in LVEF
at follow-up, PTI C0.85 was the only significant
predictor (b = 0.34; P = .04).
Figure 4 illustrates the baseline and follow-up data
for LVEF and LV volumes subdivided for patients with
viable vs non-viable myocardium, when applying the
PTI cut-off value of 0.85. Overall, an increase in LVEF
was observed in patients with PTI C0.85 (P = .002), as
well as a preservation of LVEDVi (P = .64), and a
reduction of LVESVi (P = .04). In patients with PTI
\0.85, no recovery in LVEF, LVEDVi, and LVESVi
were seen. 33% of patients with PTI C0.85 (8 out of 24)
showed an increase in LVEF of at least 5%, vs none in
the patients with PTI \0.85. Figure 5 illustrates the
functional recovery by CMR of two study subjects, in
relation to baseline PTI and DCE.
DISCUSSION
The main finding of this study is that PTI can
identify viable myocardium in patients with AMI
following successful revascularization with fairly good
diagnostic accuracy in absolute terms, and in excellent
agreement with DCE-CMR. On a segmental level, a PTI
cutoff value of 0.85 yielded the best diagnostic accuracy
for discriminating between viable and non-viable myo-
cardium. On a global level, a PTI C0.85 in infarcted
myocardium was associated with an improvement in
LVEF.
PTI as a Marker of Viability
PTI reflects the fraction of extravascular myocardial
tissue that can rapidly exchange water (i.e., PTF), in
relation to its anatomic counterpart ATF. The likelihood
of functional recovery of stunned myocardium depends
on the degree of irreversible damage (i.e., tissue necro-
sis). Assuming that necrotic tissue does not exchange
water, the main determinant of PTI is viable (perfusable)
myocardium. Consequently, dysfunctional segments
with a normal or near normal PTI are expected to be
viable because of a limited amount of myocardial
damage. In contrast, dysfunctional myocardium with a
reduced PTI is less likely to be viable because more
necrotic tissue is present. In the subacute phase after
reperfused AMI, PTI in viable segments was not
Table 2. Segmental PET and CMR data at baseline
Extent of DCE (%)
Remote 1–25 (n 5 63) 26–50 (n 5 58) 51–75 (n 5 34) >75 (n 5 25)
PTI* 0.94 ± 0.10 0.90 ± 0.12 0.87 ± 0.13** 0.82 ± 0.13** 0.77 ± 0.15**
PTF* 0.71 ± 0.10 0.67 ± 0.09 0.66 ± 0.09 0.63 ± 0.08** 0.60 ± 0.10**
ATF 0.77 ± 0.06 0.75 ± 0.09 0.77 ± 0.09 0.77 ± 0.08 0.82 ± 0.07
MBF* (mL/min/g) 0.96 ± 0.23 0.96 ± 0.22 0.95 ± 0.22 0.86 ± 0.20 0.81 ± 0.21**
MVI* n.a. 16/63 (25%) 20/58 (35%) 14/34 (41%) 19/25 (75%)
Viable* (%) n.a. 4/63 (70%) 19/58 (33%) 5/34 (14%) 5/25 (20%)
DCE, delayed contrast enhancement; PTI, perfusable tissue index; PTF, perfusable tissue fraction; ATF, anatomical tissue fraction;
MBF, myocardial blood flow; MVI, microvascular injury; n.a., not applicable
*P\ .01 (ANOVA), **P\ .01 vs remote
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Figure 1. Serial changes in (A) PTI, (B) MBF and (C) DCE
for viable and non-viable myocardial segments from baseline
to follow-up, in relation to remote myocardium. PTI, perfus-
able tissue index; MBF, myocardial blood flow; DCE, delayed
contrast enhancement; Base, baseline; FU, follow-up.
Figure 2. PTI, DCE, and MBF receiver operator characteris-
tics curves for differentiating between viable and non-viable
segments. PTI, perfusable tissue index; DCE, delayed contrast
enhancement; MBF, myocardial blood flow.
Figure 3. Serial changes in regional function from baseline to
follow-up in segments in the territory of the culprit artery,
subdivided for PTI C0.85 and PTI \0.85. PTI, perfusable
tissue index; Base, baseline; FU, follow-up.
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significantly different from remote control segments. In
contrast, PTI was significantly reduced in the non-viable
segments as compared with the remote segments.
The predictive value of PTI in AMI has been
studied previously by Yamamoto et al8 In that study,
PTI was determined in 11 patients who were success-
fully treated with thrombolysis following AMI. Of 12
dysfunctional segments at baseline, 7 showed improved
systolic wall thickening at follow-up, as measured by
echocardiography. PTI in segments that recovered aver-
aged 0.88, which is only slightly lower than the values
seen in the present study. Furthermore, PTI in viable
segments was not significantly different from remote
segments, in accordance with the present findings.
Follow-up time in the present study (97 ± 10 days)
was comparable to the study by Yamamoto et al. and
was shown to be valid for detection of myocardial
recovery after myocardial infarction.8
Complete recovery of function only occurred in
segmentswith a PTI[0.80, suggesting that at least 80%of
amyocardial segment needs to survive after AMI, in order
for it to regain function. Previous investigations in
patients undergoing revascularization therapy for chronic
MI have reported similar preconditions for tissue viabil-
ity, ranging from 0.70 to 0.80 for the PTI.20-22 Although
PTI in non-viable segments averaged 0.80, it should be
noted that a small number of non-viable segments
exhibited higher values (up to 0.99), indicating a certain
degree of overlap in PTI values between viable and non-
viable myocardium. This is, at least in part, due to the fact
that in the present study viability is expressed in a binary
(i.e. segments are graded either viable or non-viable)
rather than a gradual fashion, where the latter is likely to
be a more accurate reflection of reality23 Indeed, non-
viable segments with PTI[0.80 showed some functional
recovery at follow-up, averaging 1.0 mm, whereas non-
viable segments with PTI\0.80 showed no recovery at
all, or even exhibited dyskinesia.
PTI vs DCE in (Sub)Acute MI
Although the extent of hyperenhancement, as
assessed by CMR, was accompanied by a gradual
decrease in PTI and PTF (in line with the study
hypothesis), a systematic discrepancy was observed
between the extent of DCE and PTI with increasing
infarct size. DCE-CMR has been investigated and
validated extensively for the detection of myocardial
viability in chronic MI.24,25 Experimental studies have
shown that the extracellular contrast agent gadolinium
only accumulates in irreversibly damaged tissue, thereby
providing accurate delineation of non-viable from viable
tissue.26,27 The significance of contrast patterns in acute
MI, however, is less clear and, despite extensive
research, results are not unambiguous. In contrast to
chronic MI, which histologically is based on fibrosis and
scar tissue, (sub)acute MI causes formation of tissue
edema and/or eventual disruption of the myocyte mem-
brane, altering wash-in/wash-out kinetics of gadolinium
and increasing its volume of distribution as well, albeit
on a different pathophysiological basis.28 In addition, on
histological examination, even in so-called transmural
myocardial infarction, viable islets of cardiomyocytes
can frequently be detected within the scar region.29
Hence, areas that contain a considerable amount of
viable myocardium may still show hyperenhancement,
as the signal will be dominated by the (possibly small)
fraction of transmural necrosis.30 The physiological
consequence may be that actual infarct size is overes-
timated with DCE-CMR, as hyperenhanced areas may
be composed of a mixture of necrotic tissue and, to a
lesser extent, reversibly damaged, edematous tissue,
predominantly in the setting of (sub)acute MI. This is
highlighted by the fact that 5/25 (20%) of myocardial
segments with (near) transmural infarction (C75%
hyperenhancement) actually recovered completely dur-
ing follow-up. These numbers are in accordance with
Table 3. Univariable and multivariable regression analysis for the prediction of baseline LVEF and the
absolute change in LVEF between baseline and follow-up (D LVEF, per %)
Variable
LVEF at baseline D LVEF
Univariable Multivariable Univariable
b P value b P value b P value
PTI C0.85 0.50 0.002 0.34 0.04
MBF (mL/min/g) 0.13 0.34 -0.11 0.51
Infarct size (% LV) -0.54 \0.001 -0.16 0.34
Presence of MVI -0.54 \0.001 -0.18 0.27
Extent of MVI (% LV) -0.65 \0.001 -0.69 \0.001 -0.12 0.46
LVEF, left ventricular ejection fraction; LV, left ventricle; other abbreviations as in Table 2
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previous reports and imply that contrast enhancement is
not merely limited to areas of tissue necrosis, but also
occurs in myocardial tissue with non-critical injuries.
The fact that PTI in these recovered segments averaged
0.98 (vs 0.72 in non-viable segments, P\ .001) empha-
sizes that the main parts of these segments are capable of
rapidly exchanging water despite extensive hyperen-
hancement. Under these circumstances, DCE-CMR may
potentially cause erroneous interpretation of tissue
viability.31 The latter is illustrated in Fig. 4, which
depicts the parametric PTI and (DCE-)CMR images of
two study subjects with extensive hyperenhancement
after successfully reperfused AMI. The patient with an
inferior wall AMI (Fig. 4A) exhibits a near normal PTI,
whereas the patient with an anterior wall AMI (Fig. 4B)
shows a severely reduced PTI. Although both patients
exhibit transmural contrast enhancement of the infarcted
area, functional recovery was only observed in the
infarcted areas with preserved PTI, suggesting that
contrast enhancement may not reliably differentiate
between reversibly damaged (e.g. edematous) and irre-
versibly damaged (e.g. necrotic) myocardium.
Temporal Infarct Evolution
Whereas PTI in viable myocardium did not signif-
icantly change during follow-up, PTI in non-viable
myocardium significantly increased (albeit limited),
mainly due to a reduction in ATF. This reduction in
ATF may be the result of partial volume effects caused
by wall thinning, which was more apparent in the non-
viable myocardial segments. At follow-up, resting
myocardial perfusion was significantly decreased in
non-viable myocardium as opposed to viable myocar-
dium. This can be related to a severe reduction in
contractility due to extensive loss of cardiomyocytes,
which results in a reduction of tissue oxygen demand,
and thus MBF. Considering that contractility recovered
in viable myocardium, metabolic demand is maintained
in these segments during infarct evolution. Finally, a
significant reduction in hyperenhancement was seen
between baseline and follow-up, for both viable and
non-viable myocardium, mimicking a reduction in
infarct size. This may be attributed to several reasons
mentioned previously, being (1) overestimation of
infarct size in the (sub)acute phase of AMI as a result
of ischemia induced alterations in wash-in/wash-out
kinetics of gadolinium and volume of distribution, and
(2) infarct shrinkage during follow-up due to the
replacement of necrotic tissue by collagenous scar,
resulting in a denser, yet smaller tissue volume.
Microvascular Injury
MVI is characterized by extensive damage to the
microcirculation resulting in severely impaired tissue
perfusion, and previous studies have reported MVI as a
powerful predictor of long-term outcome32 and func-
tional recovery2,3 in patients with reperfused AMI.
Indeed, MVI was associated with a reduced LVEF at
baseline and the extent of MVI was the only indepen-
dent predictor of baseline function, as previously
reported.3 Contrary to previous observations however,
there was no significant relationship between baseline
MVI and functional recovery at a global level, although
Figure 4. Serial changes in (A) LVEF and (B) global left
ventricular volumes from baseline to follow-up in patients with
viable (PTI C0.85) and non-viable myocardium (PTI\0.85).
LVEF, left ventricular ejection fraction; LVEDV, left ventric-
ular end-diastolic volume index; LVESV, left ventricular end-
systolic volume index; PTI, perfusable tissue index; Base,
baseline; FU, follow-up.
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there was significantly less MVI in viable segments.
This apparent discrepancy between global and segmen-
tal findings may be attributed to the fact that
approximately one third of all viable segments actually
exhibited a certain degree of MVI.
Clinical Implications
The high NPV of PTI enables the use of PET to rule
out viability in dysfunctional segments after acute MI,
without the need for traditional nuclear metabolic
imaging. PTI can be obtained in less than 10 min and
radiation burden is low. The limited availability of PET
scanners worldwide and the need for an on-site
cyclotron, however, hampers its clinical applicability
and currently favor the use of alternative imaging
techniques, such as CMR, for assessing tissue viability
in patients with acute/chronic MI.
Methodological Considerations
Several methodological aspects should be taking
into consideration. First, the use of absolute wall
thickening as a means of measuring functional recovery
does not account for potential tethering of non-viable
segments to surrounding viable segments, and may
falsely give the impression of improved function.23
Second, during infarct evolution the spatial extent of
hyperenhancement on CMR is reduced, as the acutely
necrotic core is replaced by collagenous scar. This
results in shrinkage of the infarct and may introduce a
certain degree of misalignment of myocardial seg-
ments.26 Although this may have introduced bias in
favor of CMR, i.e. CMR was used to assess both wall
motion and DCE, the effect is expected to be limited
since ATF of the infarcted myocardium was comparable
between baseline and follow-up. Similarly, results from
different imaging modalities were combined and serial
analysis of myocardial segments was performed. Despite
the fact that care was taken in matching myocardial
territories, some misalignment might have occurred.
Finally, incorporation of a dobutamine stress protocol
during CMR could have further enhanced delineation
between viable and nonviable myocardial segments
based on contractile reserve.
CONCLUSION
Assessment of myocardial viability shortly after
reperfused AMI is feasible using PET. PET derived PTI
is a fairly good prognostic indicator for recovery of
myocardial function, in excellent agreement with DCE-
CMR.
NEW KNOWLEDGE GAINED
• PTI can identify viable myocardium in patients with
AMI following successful revascularization with
fairly good diagnostic accuracy in absolute terms, in
excellent agreement with DCE-CMR.
Figure 5. Two patients with AMI after successful reperfusion both showing extensive DCE; (A)
Inferior AMI with preserved PTI of the inferior wall and functional recovery at follow-up. (B)
Anterior AMI with reduced PTI of the anterior wall and no functional recovery at follow-up. AMI,
acute myocardial infarction; DCE, delayed contrast enhancement; PTI, perfusable tissue index.
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• On a segmental level, a PTI cutoff value of 0.85
yielded the best diagnostic accuracy for discriminat-
ing between viable and non-viable myocardium.
• On a global level, a PTI C0.85 in infarcted
myocardium was associated with an improvement in
LVEF.
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